CClinicalTrials.gg
CompletedNCT03660215M2PRUSSEUpdated Jun 20, 2024

Medico-social Mediation on the Prevention of the Return to Emergencies Among People in a Precarious Social Situation

An interventional study of mediation in Social Isolation, sponsored by Assistance Publique Hopitaux De Marseille. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-20.

Sponsored by Assistance Publique Hopitaux De Marseille · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
724
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This research aims to evaluate a new mode of care for precarious public through a medico-social mediation device after emergencies, with the aim of improving their care and to prevent possible complications.

The main objective is to evaluate the effectiveness of management by a medico-social mediation device set up within 48 hours after leaving emergency on the 90-day emergency readmission rate. people living in precarious situations.

prospective randomized interventional trial with two arms. Patients will complete questionnaires assessing precariousness, quality of life, health literacy, and time perspective. Eligible patients (726 subjects) are randomized : control group (usual management) or experimental group (patient is contacted within 48 hours by a medico-social mediator familiar with the territory), and followed for 90 days by the latter, in order to optimize and secure the care path.

Readmissions are identified from emergency database and Regional Emergency Terminal and documented.

Patients in the experimental group benefit from the support of a local health mediator who carries out a diagnosis of the person's needs in order to follow his or her care path in an optimal way. It implements and ensures with the patient and his entourage the follow-up of the care through his network of professionals of the social sector and the health.

The study will be under the responsibility of a multidisciplinary scientific committee experienced in public health, epidemiology and social psychology of health, in the field of emergencies, precariousness and medico-social mediation, and excellent knowledge. territories concerned.

Read the detailed description

This research aims to evaluate a new mode of care for precarious public through a medico-social mediation device after emergencies, with the aim of improving their care, to prevent possible complications of diseases related to poor / no return home care, to improve the quality of life of the people concerned, and to participate in the decongestion of emergencies.

The main objective is to evaluate the effectiveness of management by a medico-social mediation device set up within 48 hours after leaving emergency on the 90-day emergency readmission rate. people living in precarious situations.

Secondary objectives:

  • Evaluate the effectiveness of the studied CEP on the 180-day emergency readmission rate, the hospitalization rate at 30, 90 days and 180 days, the number of readmissions to emergencies within 30, 90 and 180 days of follow-up, duration of hospitalizations occurring within 180 days, subgroups of patients, reasons for readmissions to the emergency department,
  • Evaluate the impact of health literacy and temporal awareness levels on the 90 day emergency readmission rate,
  • Evaluate the impact of the initial quality of life on the 90-day readmission rate,
  • Identify predictive factors for readmission to emergencies at 30, 90 and 180 days.

Methodological approach: prospective randomized interventional trial with two arms.

Patients admitted to one of the four participating UAs meeting the inclusion / exclusion criteria of the trial will complete questionnaires assessing precariousness, quality of life, health literacy, and time perspective. Two emergency centers will be located in dense urban areas that are highly vulnerable (Marseille's northern neighborhoods); two others in less urbanized areas in which there are pockets of neo-rural precariousness. Eligible patients are randomized to emergency in one of the two arms (control: usual management) or (experimental: intervention). In this last arm, the patient is contacted within 48 hours by a medico-social mediator familiar with the territory, and followed for 90 days by the latter, in order to optimize and secure the care path. Patients are recalled at 90 days (number obtained at the signing of the consent). Patients are documented for emergency use, severity (CCMU score), primary and associated conditions, quality of life (WHOQOL-Brief), patterns and patterns of discharge. A health literacy score and a time-domain assessment (short-term PTZ) will be administered only in the experimental arm, using these scales to cover a secondary objective to examine the impact of health literacy and literacy. temporal perspective on the readmission rate. Readmissions are identified from the emergency database and Regional Emergency Terminal and documented (reason for appeal, severity score, mode and reason for leaving the study).

Patients in the experimental group benefit from the support of a local health mediator who carries out a diagnosis of the person's needs in order to follow his or her care path in an optimal way. It implements and ensures with the patient and his entourage the follow-up of the care through his network of professionals of the social sector and the health.

Patients in the control group do not have the support of the health mediator. They are only initially evaluated. Their eventual readmission is identified from the local emergency database at 30, 90 and 180 days as patients in the experimental group.

The number of subjects needed to carry out the research is 726 subjects, ie 363 subjects per group.

The statistical analyzes are carried out according to an analysis plan validated by the scientific committee of the study, with robust tools , blind (with lifting of the blind at the end of the analyzes). Use of descriptive and then analytical techniques.

The study will be under the responsibility of a multidisciplinary scientific committee experienced in public health, epidemiology and social psychology of health, in the field of emergencies, precariousness and medico-social mediation, and excellent knowledge. territories concerned.

02

Conditions studied

  • Social Isolation

Browse trials for

03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 724 is above the median of 145 across 931 interventional studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Assistance Publique Hopitaux De Marseille is the lead sponsor of 686 studies on the registry; 148 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Admitted to emergencies,
  • Social precariousness score at the EPICES scale,
  • Having made at least one visit to an emergency department during the 90 days prior to inclusion,
  • Arriving on their own or being transported to a recumbent position by firefighters or an ambulance,
  • Volunteers to participate in the study ,

Exclusion criteria

Exclusion Criteria:

Having a score of social precariousness according to the EPICES scale lower than 30, Transferred from a medico-social institution, Unable to answer a questionnaire, face-to-face with an interviewer, either for medical reasons Coming to emergencies for / with a psychiatric decompensation and / or presenting a serious mental illness and / or under the influence of psychotropes, Residing outside the areas of residence targeted by the research, Refusing to participate in the study , In situations of legal incapacity to fulfill informed consent, in particular persons under guardianship or trusteeship.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
724 participants (actual)

Study arms

  • No intervention
    control group

    usual charge

  • Experimental
    experimental group

    Mediation: The mediator will intervene on several levels: planning of care according to the medical prescriptions on a support adapted and comprehensible by the patient according to his level of health literacy and his linguistic capacities, coaching on the management of the chronic diseases, possible orientation towards a workshop of therapeutic education, appointments calendar, clear indication of treatment changes, provision of contact information for allied health professionals , assistance in making appointments, possible accompaniments at a professional health.

    Other: mediation

Interventions

  • Othermediation

    support throughout their care journey during the 90 days following an emergency visit. This support will be carried out by a specific staff trained in medico-social mediation

06

What researchers measure

Primary outcomes

  1. numbers of readmission to hospital emergencies

    90-day readmission rate to hospital emergencies

    Time frame: 90 days

07

Study locations

1 site
  • Assistance Publique Des Hopitaux de Marseille
    Marseille, Paca 13354, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03660215
Lead sponsor
Assistance Publique Hopitaux De Marseille
Responsible party
Sponsor
First posted
Sep 6, 2018
Start date
Feb 6, 2019
Primary completion
Aug 4, 2022
Completion
Aug 4, 2022
Last update
Jun 20, 2024

Study contacts

EMILIE GARRIDO PRADALIE
study director · APHM

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion